Drug Trial Protocols
LANCET 2(8570): 1286, 28 November 1987
Showing items related by title, author, creator and subject.
The Financing of Drug Trials by Pharmaceutical Companies and Its Consequences. Part 1: A Qualitative, Systematic Review of the Literature on Possible Influences on the Findings, Protocols, and Quality of Drug Trials Schott, Gisela; Pachl, Henry; Limbach, Ulrich; Gundert-Remy, Ursula; Ludwig, Wolf-Dieter; Lieb, Klaus (2010-04)In recent years, a number of studies have shown that clinical drug trials financed by pharmaceutical companies yield favorable results for company products more often than independent trials do. Moreover, pharmaceutical ...
Clinical trial design issues raised during recombinant DNA advisory committee review of gene transfer protocols Scharschmidt, Tiffany; Lo, Bernard (2006-04)
Performance of Research Ethics Committees in Spain. a Prospective Study of 100 Applications for Clinical Trial Protocols on Medicines Dal-Re, Rafael; Espada, Julian; Ortega, Rafael (1999-06)OBJECTIVES: To review the characteristics and performance of research ethics committees in Spain in the evaluation of multicentre clinical trial drug protocols. DESIGN: A prospective study of 100 applications. SETTING: Forty-one ...